Nuclear NFATc1 Causes Development of Fms-like Receptor Tyrosine Kinase 3 Receptor (FLT3) Internal Tandem Duplication Mutation-Positive (FLT3-ITD) Acute Myeloid Leukemia (AML) and Mediates Drug Resistance

被引：1
|
作者：
Solovey, Maria A. [1 ]
Wang, Ying [1 ]
Gattenloehner, Stefan [2 ]
Hessmann, Elisabeth [3 ]
Metzelder, Stephan [1 ]
Michel, Christian [1 ]
Ellenrieder, Volker [3 ]
Goethert, Joachim R. [4 ]
Neubauer, Andreas [1 ,5 ]
Burchert, Andreas [1 ]
机构：
[1] Univ Hosp Giessen & Marburg, Dept Hematol & Oncol, Marburg, Germany
[2] Univ Hosp Giessen, Dept Pathol, Giessen, Germany
[3] Univ Hosp Gottingen, Dept Gastroenterol, Gottingen, Germany
[4] Univ Hosp Essen, West German Canc Ctr, Dept Hematol, Essen, Germany
[5] Univ Giessen & Marburg, Med Ctr, Univ Marburg, Dept Internal Med & Hematol Oncol & Immunol, Marburg, Germany
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.1722.1722
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1722
引用
收藏
页数：5
相关论文
共 50 条
  • [31] QuANTUM-First: Efficacy by Age in Newly Diagnosed (nd) Patients With FMS-Like Tyrosine Kinase 3-Internal Tandem Duplication-Positive (FLT3-ITD+) Acute Myeloid Leukemia (AML)
    Erba, Harry P.
    Patkowska, Elzbieta
    Cortes, Jorge
    Perl, Alexander E.
    Sekeres, Mikkael A.
    Dombret, Herve
    Amadori, Sergio
    Wang, Jianxiang
    Levis, Mark J.
    Schlenk, Richard F.
    Liu, Li
    Kamel, Yasser Mostafa
    Imadalou, Karima
    Laadem, Abderrahmane
    Lesegretain, Arnaud
    Montesinos, Pau
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S299 - S299
  • [32] Quantification of the FLT3 internal tandem duplication is a reliable marker for monitoring measurable residual disease in acute myeloid leukemia with FLT3-ITD mutations
    Wang, Meng-Miao
    Huang, Si-Man
    Huang, Yuan-Hong
    Zhang, Jian
    Li, Hui-Ying
    Ge, Shuai-Shuai
    Wan, Chao-Ling
    Wang, Miao
    Liu, Hai-Hui
    Cao, Han-Yu
    Wang, Zi-Hao
    Tan, Kai-Wen
    Pang, Hong-Feng
    Lyu, Xiao-Yu
    Liu, Song-Bai
    Dai, Hai-Ping
    Xue, Sheng-Li
    Qiu, Qiao-Cheng
    BONE MARROW TRANSPLANTATION, 2024, : 412 - 414
  • [33] A FLT3 tyrosine kinase inhibitor is selectively cytotoxic to acute myeloid leukemia blasts harboring FLT3 internal tandem duplication mutations
    Levis, M
    Tse, KF
    Smith, BD
    Garrett, E
    Small, D
    BLOOD, 2001, 98 (03) : 885 - 887
  • [34] Soluble phosphorylated fms-like tyrosine kinase III. FLT3 protein in patients with acute myeloid leukemia (AML)
    Ravandi, F.
    Jilani, I.
    Estey, E.
    Kantarjian, H.
    Dey, A.
    Aguilar, C.
    Jitkaroon, C.
    Giles, F.
    O'Brien, S.
    Keating, M.
    Albitar, M.
    LEUKEMIA RESEARCH, 2007, 31 (06) : 791 - 797
  • [35] A ZEBRAFISH MODEL OF FMS-LIKE TYROSINE KINASE 3 (FLT3) IN DEFINITIVE HEMATOPOIESIS AND HUMAN ACUTE MYELOID LEUKEMIA
    He, Bailiang
    Man, Cheuk Him
    Shi, Xiangguo
    Ma, Alvin C. H.
    Leung, Anskar Y. H.
    EXPERIMENTAL HEMATOLOGY, 2013, 41 (08) : S48 - S48
  • [36] Cytoplasmic Nucleophosmin (NPMc plus ) Mutations and FMS-Like Tyrosine Kinase 3 (Flt3) Internal Tandem Duplication (ITD) Mutations Cooperate to Cause Leukemia In a Mouse Model
    Rau, Rachel E.
    Magoon, Daniel
    McIntyre, Emily
    Li, Li
    Greenblatt, Sarah
    Huso, David
    Pandolfi, Pier Paolo
    Small, Donald
    Brown, Patrick
    BLOOD, 2010, 116 (21) : 68 - 68
  • [37] Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies
    Carullo, Gabriele
    Rossi, Sara
    Giudice, Valentina
    Pezzotta, Alex
    Chianese, Ugo
    Scala, Pasqualina
    Carbone, Sabrina
    Fontana, Anna
    Panzeca, Giovanna
    Pasquini, Silvia
    Contri, Chiara
    Gemma, Sandra
    Ramunno, Anna
    Saponara, Simona
    Galvani, Francesca
    Lodola, Alessio
    Mor, Marco
    Benedetti, Rosaria
    Selleri, Carmine
    Varani, Katia
    Butini, Stefania
    Altucci, Lucia
    Vincenzi, Fabrizio
    Pistocchi, Anna
    Campiani, Giuseppe
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2024, : 2125 - 2142
  • [38] Internal Tandem Duplication Mutation Of FLT3 (FLT3/ITD) Induces Increased Homologous Recombination DNA Repair Activity, Drug Resistance and Sister Chromatid Exchanges In Acute Myeloid Leukaemia (AML)
    Gaymes, Terry J.
    Darling, David C.
    Mufti, Ghulam J.
    BLOOD, 2013, 122 (21)
  • [39] Synergistic effect of FMS-like tyrosine kinase-3 (FLT3) inhibitors combined with a CDK7 inhibitor in FLT3-ITD-mutated acute myeloid leukemia
    Koo, Bon-Kwan
    Choi, Eun-Ji
    Moon, Ju Hyun
    Kim, Ji Yun
    Park, Hyunkyung
    Park, Han-Seung
    Choi, Yunsuk
    Lee, Jung-Hee
    Lee, Kyoo-Hyung
    Choi, Eun Kyung
    Kim, Eunji
    Lee, Je-Hwan
    Hur, Eun-Hye
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [40] Primary acute myeloid leukemia (AML) cells with the FLT3 internal tandem duplication (ITD) and absence of wild type (WT) FLT3 (FLT3ITD/- genotype) are distinct from AML with either FLT3wt/wt or FLT3ITD/wt genotypes.
    Whitman, SP
    Guimond, M
    Blaser, B
    Klisovic, M
    Vukosavljevic, T
    Bruner, RJ
    Ruppert, AS
    Becknell, B
    Barbosa, X
    Griffin, J
    Briesewitz, R
    Caligiuri, MA
    BLOOD, 2002, 100 (11) : 89A - 89A
12345